Company

Thermosome GmbH

Thermosome GmbH develops tumor-targeted cancer therapies that combine localized drug delivery with immune stimulation.

About

Thermosome GmbH is a biopharmaceutical company developing targeted tumor therapies that combine localized drug delivery with immune stimulation, with licensing and co-development deals with healthcare and pharmaceutical partners. Founded in 2010 and headquartered in Munich, Germany, by Lars Lindner, Martin Hossann and Pascal Schweizer, who is also CEO, the company raised EUR 1.9 million from Bayern Kapital and High-Tech Gründerfonds on August 12, 2016, bringing total funding to EUR 1.9 million at a company valuation of EUR 14.34 mn.

1Funding rounds

2Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in